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ABSTRACT

Endocannabinoids, and the fatty acid amides from which they are a member,
have garnered greater scientific interest in the last two decades due to their
cannabimimetic properties. The most well-known of these is anandamide, which has
thus far been discovered in several species of animal ranging from C. elegans, fruit
flies, to bovine and humans. Because of the importance and increasing impact of
these compounds a brief overview is presented herein, with a major focus on the Nacyldopamines due to the direct impact they potentially pose to human physiology.
Secondly, the detection and quantitative analysis of these molecules was
conducted in the recently fully genome sequenced honeybee and red flour beetle,
due in part to recent research showing the existence of these molecules in D.
melanogaster, to which no known cannabinoid receptors had been found to date.
Interest in these potentially new model organisms may provide additional insight
not only into the endocannabinoids but also as potential targets for protection of
honeybees and pest control of red flour beetles.
Utilizing established HPLC-MS methods for the detection and quantification of
these compounds provided a series of endogenous results for these molecules
within both farmed and feral honeybees and the red flour beetle. Additionally, a
protein

sequence

and

motif

homology

study

with

a

newly

discovered

acyltransferase from Fruit flies shows strong evidence that a similar enzyme is
expressed in both honeybees and red flour beetles. Therefore providing future steps
for the continuation of this research to better elucidate and quantify the
endocannabinoids as well as determine the biosynthetic metabolism within these
organisms.

vii

CHAPTER 1:
INTRODUCTION, BACKGROUND AND CURRENT REVIEW OF
ENDOCANNABINOIDS/FATTY ACID AMIDES
1.1

Introduction to Endocannabinoids (eCBs) and Fatty Acid Amides (FAAs)
The detection of biological fatty acid amides, and their metabolites, dates

back to the initial discovery in horse urine by Justus von Liebig in 1829. (1) The
biological role of these bioactive lipids are still of importance within the biochemical
and medical fields and have been related to physiological conditions ranging from
diabetes and renal function to autism and infections. (2) Long-chain fatty acid
amides (FAAs), in which the long-chain primary fatty acid acyl group is the defining
characteristic, were first extracted and characterized starting in 1957. (3) Several
classes of FAAs are now currently known, including derivatives of important
biologically and neurologically-active compounds such as N-acylethanolamines and
N-acyldopamines (Table 1.1). (4)
Endocannabinoids (eCBs) are defined as endogenous cannabimimetic FAAderived molecules that illicit physiological effects similar to those of the active
molecules

present

in

marijuana

and

similar

cannabis

plants,

Δ 9-

tetrahydrocannabinol and cannabidiol, from which the term is derived. (5)
Additionally, endocannabinoids are structurally characterized as lipid mediators with
either long-chain saturated, unsaturated or polyunsaturated fatty acid moieties.
Like the related FAAs, eCBs can be classified as amide, ester or ether derivatives.
1

The detection of N-arachidonylethanolamine in 1992 in the porcine brain marked
the

initial discovery

of a fatty acid amide

compound shown to

produce

endocannabic effects (commonly known as anandamide, from the ancient Sanskrit
word for “bliss”). (6) Anandamide (AEA) is thus considered the prototypical
endocannabinoid.
Over

the

last

two

decades

several

additional

endogenous

eCB/FAA

derivatives have been discovered in organisms ranging from C. elegans (7), fruit
flies (8), reptiles (9) bovine (10), sheep (11), mice (10), rats (12, 13) and humans
(14, 15) to even fungi (16). Additionally, there is evidence to suggest that eCBs are
also present in chocolate. (17) A select group of relevant eCB/FAA derivatives and
known N-acyl moieties are presented in Table 1.2.
Ongoing research into the endogenous biosynthesis and function of these
molecules continues to show their primary location in brain or central nervous
system tissue, such as the substantia nigra (15), specific neuronal cells (10),
cerebrospinal fluid (17), choroid plexus (10) and blood serum (19). The early
research into the function, potential receptor and bioactivity of anandamide used
extracted rat synaptic tissue (6) and live mice (18). It was the initial study by
Devane that suggested the potential receptor for AEA as being cannabinoids in vivo.
(6)
The primary receptors which have been extensively studied with eCBs as
potential ligands include mammalian cannabinoid receptors, CB1/CB2, and the
transient receptor potential vanilloid type 1 channel, TRPV1. (5) Other research has
shown that eCBs may also act as ligands to receptor proteins such as G-protein-

2

coupled receptor 119 (GPR119) and peroxisome proliferator-activated receptor
gamma and alpha (PPARγ/PPARα). (19, 20)
Though the exact function of these receptors is not completely known
numerous studies suggest several notable physiological effects including the
modulation of pain perception, sleep induction, body temperature, locomotion,
appetite and even fear and anxiety (Table 1.2). (21) It is primarily due to these
effects that the eCBs/FAAs are an ever-increasing research area of interest, both as
potential therapeutic targets and to better understand the physiology involved.

1.2

Anandamide and Other NAEs

Figure 1.1: Major NAE Derivatives, incl. anandamide (AEA).
As stated, anandamide is considered the prototypical endocannabinoid not
only because it was the first discovered within the eCB metabolome but also due to
the high research interest it garnered by its physiological roles to date, those roles
being cannabimimetic in nature, and is only one of several within the Nacylethanolamine (NAE) family (Fig. 1.1).

3

Table 1.1: Families of endocannabinoids/fatty acid amides, major acyl forms and
known endogenous organisms. R2 represents the amino acid group.
eCB/FAA Class

Major N-acyl Moieties, R1

Endogenous
Organisms

Palmitoyl (C14:0)
Oleoyl (C18:1 cis-Δ9)
Arachidonoyl (C20:4 cis-Δ5,8,11,14)

C. elegans
Fruit Fly
Reptiles
Rodents
Cows & Pigs
Cats & Rabbits
Human

Palmitoyl (C14:0)
Oleoyl (C18:1 cis-Δ9)
Arachidonoyl (C20:4 cis-Δ5,8,11,14)

Fruit Fly
Rodents
Cows & Pigs
Cats & Rabbits
Human

Palmitoyl (C14:0)
Oleoyl (C18:1 cis-Δ9)
Arachidonoyl (C20:4 cis-Δ5,8,11,14)

Fruit Fly
Rodents
Cows
Human

Palmitoyl (C14:0)
Palmitoleoyl (C16:1 cis-Δ9)
Oleoyl (C18:1 cis-Δ9)
Linoleoyl (C18:2 cis,cis-Δ9,12)
Eicosenoyl (C20:1 cis-Δ13)
Arachidonoyl (C20:4 cis-Δ5,8,11,14)

C. elegans
Fruit Fly
Rodents
Cows & Pigs
Cats & Rabbits
Human

N-Acylethanolamine (NAE)

N-Acylamino acid (NAA)

N-Acyldopamine (NAD)

Primary Fatty Acid Amide
(PFAA)

4

Table 1.2: The major eCB/FAA groups and known receptors with biological effects
CB1/CB2
TRPV1
PPARγ/PPARα

Sleep, Pain,
Body
Temperature,
Appetite &
Anxiety

N-Arachidonoylglycine
N-Arachidonoyltaurine

CB1/CB2
TRPV1
PPARγ/PPARα

Pain, Body
Temperature &
Antiinflammatory

N-Arachidonoyldopamine
N-Oleoyldopamine
N-Palmitoyldopamine

CB1/CB2
TRPV1
PPARγ/PPARα

Sleep, Pain &
Anxiety

Eicosenoamide
Linoleamide
Oleamide
Palmitamide

CB1
PPAR
5-HT1A/2A

N-Acylethanolamine
(NAE)

Anandamide
N-Oleoylethanolamine
N-Palmitoylethanolamine

N-Acylamino acid
(NAA)

N-Acyldopamine
(NAD)

Primary Fatty Acid
Amide (PFAA)

Sleep, Pain,
Body
Temperature,
Appetite &
Anxiety

Fride and Mechoulum, colleagues of Devane, were the first to provide an in
vivo analysis of the effects of anandamide within a mammalian organism (mice).
(18) In general, cannabis’ effects on mammals are dose-dependent, and thus range
from simultaneous depression and stimulation at low doses to more extensive
central depression at high doses. Using a classic tetrad series of behavioral tests
with anandamide and Δ8-THC for these cannabic effects it was shown that the two
compounds produced remarkable similarity in the expected effects from the
majority of test animals. Examples of these tests included antinociception
(decreased pain sensation), measured hypothermia and physical activity. (22) Such
research also concluded that, as cannabic effects occur in the central nervous

5

system, anandamide readily crosses the blood-brain barrier and suggested possible
cellular transporters specific to these compounds.
As a result of the early research into the in vivo effects of anandamide it was
clear that specific receptors existed for these molecules. Receptors for the active
psychotropics in Cannabis had already been known, the cannabinoid receptors 1
and 2 (CB1/CB2); and the results by Fride and Mechoulom lent clear evidence that
anandamide and other endocannabinoids were endogenous ligands to these
receptors. (23, 24) What was still unclear at that time was the biological purpose
and biosynthesis of molecules like anandamide. Interestingly enough anandamide is
one of the least abundant of the NAEs in the mammalian brain, consisting less than
10% of the total endogenous amounts to date of NAEs known. Several other NAEs
were since detected and measured within various organisms since the initial
discovery

by

Devane

et

al.,

including

N-palmitoylethanolamine

(PEA),

N-

oleoylethanolamine (OEA) and various others ranging from N-stearoylethanolamine
(SEA) and N-linoleoylethanolamine (LEA) to N-dihomo-γ-linoleoylethanolamine
(DLEA) and N-docosatetraenoylethanolamine (DEA). (21)
In addition to the cannabinoid receptors, other receptors were discovered to
be paired to endocannabinoids such as the transient receptor vanilloid type 1
(TRPV1), transient receptor potential of melastatin 8 (TRPM8), G-coupled-protein
receptor 119 and peroxisome proliferator-activated receptors alpha and gamma
(PPARα,γ). (25, 26, 20,27, and 28) For anandamide the binding constants with
these receptors vary greatly (Kd = 61 – 11,000 nM), with higher affinity for CB1/CB2
and lower affinities for PPARγ. (21) A select few NAEs, like SEA, have exhibited
cannabimimetic effects without binding to any known cannabinoid receptors, thus

6

suggesting the possible existence of a heretofore unknown cannabinoid receptor
(potentially, “CB3”). (29)
Furthermore, much of the research into the various eCB NAEs like AEA, OEA
and PEA have continued to suggest what has become known as the “entourage
effect,” in which interactions of these molecules can augment substrate-ligand
binding. (30) This effect may explain some of the observed competing activities of
these NAEs for the various receptors, and the large variations in endogenous
amounts, due to the promiscuity of NAEs for the NAE-degradation enzymes known
for anandamide; thus resulting in cellular concentration stabilization. (21, 30, and
31)
Despite the extensive research into the biological nature of anandamide and
the NAEs the biosynthetic and degradation routes for these molecules is complex
with few clear answers thus far. Several articles have provided sound arguments for
several biosynthetic routes, with the most widely accepted among them currently
being

the

N-acylphosphotidylethanolamine

(NAPE)

specific

phospholipase-D

dependent (NAPE-PLD) synthesis. The NAPE-PLD route catalyzes the cleavage of
NAPE into the corresponding NAE and phosphotidic acid. (32) Several additional
routes related to these and similar enzymes have been proposed as well. A more
thorough discussion can be accessed from Waluk, et al., 2014 (21).
The degradative routes for the NAEs are also equally as complex and varied.
Current literature strongly suggests the use of fatty acid amide hydrolase (FAAH)
for the hydrolytic degradation of NAEs to ethanolamine and free fatty acid, while
other research also suggests an oxidative pathway to the N-acylated amino acid Nacylglycine via fatty aldehyde dehydrogenase. (33, 34). Several of the metabolites
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from these pathways have been implicated in additional bioactivity, suggesting
alternative routes of regulation. (35, 36, and 37) Indeed, research has progressed
with FAAH inhibition as a potential therapeutic route for the treatment of various
neuropathological states such as Alzheimer’s and Parkinson’s diseases. (38)
Recent research into the physiological roles of the NAEs has added to an
ever-increasing list beyond those previously mentioned. Some of these roles include
human reproduction and fertility (39, 40). Continued research also includes the use
of NAEs as anxiolytics and antidepressant therapeutics (41, 42).

1.3

N-Acyldopamines: Physiological Role, Biosynthesis and Degradation
Because of the substantial physiological role that dopamine occupies in

vertebrate species the N-acyldopamine-derived endocannabinoids are especially of
interest in the scope of this review.

Figure 1.2: The Four Major N-Acyldopamine eCB Derivatives.
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1.3.a.

Physiological Role
As first reported by Huang, et al. in 2002, a small number of N-

acyldopamines, such as N-arachidonoyldopamine (NADA), have been identified in
mammalian brain tissues, with the highest concentrations within the hippocampus,
striatum and cerabellum. (43) Additionally, NADA was shown to be a potent agonist
(EC50 ≈ 50 nM) of the nonselective cation channel TRPV1 in both human and rats
with similar efficacy to that of capsaicin, a non-endogenous mediator of TRPV1. The
Huang group described the ability of NADA to induce TRPV1-mediated hyperalgesia
in rats intradermally (EC50 = 1.5±0.3 μg). Before direct studies of NADs with TRPV1
were conducted, previous research indicated their role in pain mediation as a
molecular transducer of chemical and physical nociceptive stimulus. (44) Shortly
before the endogenous detection of NADs, NADA was found to be a greater CB1
agonist than anandamide, producing: hypothermia, hypo-locomotion, catalepsy,
and analgesia. It was also found, along with N-pinolenoyldopamine and Ndocosapentaenoyldopamine, to inhibit FAAH activity. (45)
Chu and colleagues of the Huang group had shown the existence of
endogenous levels of additional long-chain N-acyldopamines: N-stearoyldopamine
(STEARDA), N-palmitoyldopamine (PALDA) and N-oleoyldopamine (NOLDA). (46) In
this study, it was shown that the saturated fatty acyl derivatives STEARDA and
PALDA had no effect on calcium influx or thermal hyperalgesia via the TRPV1
receptor. However, NOLDA, an unsaturated derivative, caused calcium influx and
thermal hyperalgesia via TRPV1 with similar potency to that of NADA (EC50 ≈ 36 nM
and ≈ 17 nM, respectively). Unlike NADA, NOLDA was shown to be a weak ligand

9

for CB1. Like NADA, NOLDA was shown to be a ligand for the anandamide
membrane transporter but a poor substrate for FAAH (therefore suggesting an
additional route of degradation). The dichotomy between the saturated and
unsaturated fatty acyl derivatives of N-acyldopamine suggests the requirement of
an unsaturated acyl chain for optimal binding and function with TRPV receptors. The
key seminal research by Huang, Chu and colleagues had shown that endogenous Nacyldopamines are putative substrates to TRPV1 receptors and opened the door to
research in the field of these molecules and their neurological function.
It has also been noted that TRPV1 is the only one in the family of TRPV
receptors that is activated by both endogenous long-chain acyl derivatives and
capsaicin. (47) PALDA and STEARDA were studied as enhancers of the binding of
other NADs to the TRPV1 receptor. It was found that the EC50 of NADA on the
TRPV1 receptor was significantly lowered in the presence of PALDA and STEARDA
(from 90 nM to 30 nM). This enhancement was also found to be true for
anandamide on Ca2+ levels in the studied HEK-293 cells overexpressing human
TRPV1. At low pH, it was discovered that PALDA and STEARDA could significantly
increase Ca2+ levels in the cells. Hyperalgesia was then tested in the rat hind paw
using a radiant heat source. It was determined that the observed sensitivity to heat
was much higher in the rat hind paws treated with both N-arachidonoyldopamine
and STEARDA than either of the two molecules alone. STEARDA and PALDA had
thus been shown to modulate the activity of TRPV1 under specific conditions,
leading to a sensitization of the receptor with respect to these ligands. Thus, it was
suggested that there is an entourage effect in the mechanism of action of the N-
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acyldopamines with TRPV1, which has also been seen with anandamide and the Nacyldopamines upon TRPV1. (30)
Early research by Pokorski, et al. showed the ability of NOLDA to cross the
blood brain barrier, thus suggesting its use as a transporter of dopamine into the
brain. (48)
Focus on the hyperalgesic/analgesic functions of NADs continued with the
TRPV and CB receptors. Bianchi, et al. examined whether NADA, NOLDA, and AEA
affected TRPV1 receptors in HEK293 and 1321N1 brain astrocyte cells by measuring
the levels of calcium influx. (49) NOLDA was shown to have a reduced effect
compared to NADA and AEA in HEK293 cells and markedly so in 1321N1 cells, while
decreases in pH increased this difference. Additional research indicates that NOLDA
could exert cardiac protective effects mediated by TRPV1 in wild-type mice when
compared to TRPV1-null mutant mice. (50) The anti-nociceptive potential of NADA,
based on hyperalgesia research, was further established by studying the interaction
of NADA and endomorphin-1 in rats at the spinal level. (51) NADA was shown to
have dose-dependent anti-hyperalgesia effects but was 5.4 times less potent than
endomorphin-1. Additionally, both TRPV1 and CB1 antagonists/inverse agonists
reduced these effects at higher concentrations.
Continued research with NADs has now provided evidence that these
molecules are potential mediators of neurological function. (52) NADA’s action upon
dopaminergic neurons has been shown to be mediated by glutaminergic/GABAergic
transmission via TRPV1/CB1 receptors, thus suggesting a role for NADs in synaptic
transmission regulation. This study hypothesized that the activation of either TRPV1
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or CB1 by NADA was caused by increases in glutaminergic and GABAergic
transmission

respectively.

NADA

may

also

show

inhibitory

aspects

upon

dopaminergic neurons with glutaminergic transmission via the CB1 receptor. Further
work by Ferreira et al. in 2009, had shown that NADA, NOLDA, and PALDA were
found to cause the uptake of calcium and the release of dopamine and glutamate in
striatal nerve terminals, possibly by ligand-gated ion channels, which continued to
occur in TRPV1-null mutant mice. (53) TRPV1 antagonists and the absence of
potassium indicated no change in this effect, while Gd3+ inhibited the effect with
high potency in low nanomolar ranges.
Earlier work with N-acetyldopamine has shown it to be an inhibitor of
sepiapterin

reductase,

tetrahydrobiopterin

(an

an

intermediate

enzyme

cofactor

enzyme
for

the

in

the

biosynthesis

biosynthesis

of

of

various

neurotransmitters). (54) Recent research by Grabiec and colleagues has indicted
that NADA exerts neuro-protective effects via CB1 receptors, but not with TRPV,
after excitotoxic damage. (55) These effects were blocked by the AM251 CB1
receptor antagonist and absent in CB1-null mutant mice. This work hypothesized
the role of NADs as novel drug targets to mitigate neuronal damage.
Recent research on T-type calcium channels with NADs has indicated their
potential as anti-epileptics. (56) NADA was shown to potently inhibit recombinant
human T-type calcium channels (EC50 = 300nM-1µM). NOLDA gave similar results
while PALDA had miniscule results. For a more rigorous review of N-acyl amino
acids and neurotransmitters on these various other receptors, the reader is
encouraged to refer to Conner, et al. 2010. (56)

12

Explorations

in NAD research have indicated their potential role as

neurobiological anti-inflammatory leads. (57, 58) NADs have been shown to induce
increases in COX-2 expression within brain endothelial cells via regulation of PGE2
and PGD2, thereby mediating prostaglandin production. (59) Furthermore, Dang
and others reported that NADs and analogues are potent anti-inflammatory leads
against pro-inflammatory mediators/cytokines such as TNF-α. (60, 61) Additionally,
it is noted that NADA and other endocannabinoids stimulate the transcription
activity of PPARγ, a key enzyme in fatty acid metabolism. (58) As endocannabinoids
are known to be part of the eicosanoid biosynthetic pathway the action of NADs on
these systems may potentially be negative feedback regulation pathways.
Additional research with NADs outside of their traditional hyperalgesia effects
has led to recent research into their potential role as thermogenic (anti-obesity)
drugs. Research conducted by Mahmmoud and colleagues has shown NADA to be
an uncoupling agent of sarcoplasmic reticulum Ca2+-ATPase (SERCA). (62) Earlier
work by Sharkey and colleagues had indicted NAD’s roles as anti-emetics with
CB1/TRPV1 receptors in ferrets. (63) The results showed that NADA reduced the
effects of emesis and was similarly inhibited by the antagonist AM251 at 10 mg/kg.
Their research further indicated that endocannabinoids like NADs preferentially
inhibit emesis in the brain stem via CB1 when compared to TRPV1.
Non-cannabinoid and “orphaned” G-protein coupled receptors have also been
proposed as potential targets of NADs (in particular GPR55 and GRP119) and have
shown similar effects with other endocannabinoid receptors and their corresponding
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effects, such as inflammation mediation. Additionally, NADA has been shown to
have activity with TRPM8, a receptor similar in function to TRPV1.

1.3.b. Biosynthesis and Degradation
A primary question of NADs as eCBs in the mammalian system is the discrete
biosynthetic and degradation processes in vivo and is considered a primary goal of
NAD-eCB research.
For the biosynthesis of NADs the primary question is how and where the NAD
precursors acquire the acyl group. Huang and colleagues initially proposed the
biosynthesis of NADs from the formation of acyl-CoAs via acyl-coA synthetase and
their subsequent conjugation with dopamine via an acyl transferase (see Figure
1.3, Pathway IIb,c). (10, 43) Degradation by FAAH was proposed, for which known
metabolites exist (Fig. 1.5). Additional research by Huang and colleagues gained
further evidence for these hypotheses as well as a possible biosynthetic route from
N-acyltyrosines (NATyro) using the pre-existing dopamine biosynthetic enzymes of
tyrosine decarboxylase (TDC), tyrosine hydroxylase (TH) and DOPA decarboxylase
(DDC) (Fig. 1.3 and 1.4). Evidence was also shown for an alternative degradation
pathway via methylation of NADs by catechol-O-methyltransferase (COMT) (Fig.
1.5). However, degradation by COMT was slow, suggesting metabolism by
methylation as a partial or secondary route.

In the Huang study, it was further

shown that radiolabeled arachidonic acid with dopamine or tyrosine both produced
radiolabeled NADA, including evidence of the formation of a radiolabeled NADA-like
molecule from tyrosine with the inhibition of tyrosine hydroxylase. Such research
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suggests that both of the proposed pathway sets shown herein are possible (Figs.
1.3 and 1.4).
Recently, Hu and colleagues further reported on these two possible
biosynthetic pathways for the NADs. (64) In their study it was proposed that NAD
biosynthesis required TH in the dopaminergic terminals, thus further suggesting the
presence of a putative NATyro or N-acyltyramine (NATyra) derivative. Though an
NATyro derivative was found within rat brains it was determined not to be an
intermediate in NAD biosynthesis. This conclusion was due to inhibiting TH, which
showed no increase in NATyro but a subsequent decrease in NAD levels (27% of
control). Additionally, this study showed that radiolabeled NATyro gave very low
conversion to N-acyl-L-DOPA (NADOPA) with TH incubation, compared to the
natural molecules, indicating that NATyro is a poor substrate for TH. Incidentally,
radiolabeled NADOPA was shown not to be a direct precursor of NAD in vivo,
thereby implying the possibility that N-acylation does not occur in conjunction with
NATyro-dependent

DOPA

decarboxylase.

Furthermore,

mammalian

brain

incubations with dopamine and arachidonoyl-coA/arachidonic acid phospholipid
esters gave no detectable levels of the expected NAD, thus suggesting that
acylation occurs prior to the final conversion to dopamine. As a result of this data it
was concluded that NAD biosynthesis likely does not occur via the acylation and
metabolism of NATyro or NADOPA in conjunction with either TH or DDC (Fig 1.4,
Tyrosine-dependent Pathway Ib) nor is the acyl-coA-mediated acylation of
dopamine likely as well (Fig. 1.3, Pathways IIa and IIb). Additional studies by
Bezuglov and colleagues upheld this hypothesis by showing that the biosynthesis of
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NATyro was not detected in rat liver and nerve tissues, while NADs and Nacylphenylalanine were detected. (65)
Hu, et al., further studied the second proposed biosynthetic pathway
involving the direct condensation of a free fatty acid with dopamine (Fig 1.3,
Pathway IIc). (64) Their study was conducted via rat brain incubations with
radiolabeled arachidonic acid or radiolabeled dopamine. The expected radiolabeled
NADA was detected, with no indication of NADA in buffer or boiled membranes
(control). Based on those results, FAAH-inhibited rats and FAAH-knockout mice
were examined with controls to show marked increases in AEA and decreases in
NADA for both animals, supporting a possible FAAH-mediated NAD biosynthetic
pathway. Additionally, it was reported that NADA was a poor substrate for
recombinant FAAH while AEA gave high levels of hydrolysis to the free fatty acid.
However,

small

amounts

of

NADA

production

were

detected

with

AEA/dopamine/FAAH incubations despite steps taken to eliminate possible mass
spectrometry carry-over. It was thus concluded that the biosynthesis of NADs likely
involves an enzyme-mediated condensation of a free fatty acid with dopamine
rather than an acyl-coA. FAAH may be a possible conjugation enzyme and/or a
rate-limiting enzyme for the release of free fatty acid from the corresponding
primary fatty acid amide. It was noted, however, that FAAH is an integral
membrane protein and that recombinant FAAH is unbound in vitro, likely affecting
its chemistry. Earlier research could suggest the possibility of a negative feedback
route between FAAH and NADA, if FAAH is indeed involved in the biosynthesis of
NADs. (45)
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Recent research into the degradation of NADs has lent increased evidence
towards methylation by COMT, which has been found to be an inactivator of NADA
after interaction with the TRPV1 receptor (Fig. 1.5). (66, 67)
Akimov and colleagues proposed the oxidation of NADs via pmNOX, and
more recently have shown the sulfation of NADs via aryl sulfotransferases (AST).
(68, 69) It was determined that NADs (arachidonoyl-, oleoyl- and cervonoyl-) were
sulfated via AST in rat liver, spinal cord and brain homogenates with relatively
robust activities compared to COMT- and FAAH-mediated degradation pathways
previously proposed.
Concurrently, work by Rimmerman et. al. indicate that NADA is metabolized
by

Cytochrome

P450

to

the

observed

omega/omega-1

hydroxylated

NAD

metabolites. (70) These metabolites were suggested to have a wider range of
effects with lower potency.

NH2
COOH

HO
OH

L-DOPA

NH2
HO

Pathway IIa
Acyl-CoA Synthetase
Fatty acid-coA
DOPA Decarboxylase
Pathway IIb
Acyl-CoA Synthetase
Fatty acid-coA

H
N
HO

R2

N-Acyldopamine
OH

R2 = Acyl chain

H
OH Dopamine

Acyl Transferase
Free fatty acid
Pathway IIc

Figure 1.3: Proposed L-DOPA/Dopamine-Dependent NAD Biosynthetic Pathways.
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1.4 Conclusions
Endocannabinoid/fatty acid amide research is an ever-evolving and complex
field of research within biochemistry and molecular biology. Other families of these
molecules, such as the N-acylamino acids and primary fatty acid amides, have
yielded research similar to those discussed herein but a thorough review is not
within the scope of this literature. However, one key report by Dempsey, et al.,
recently produced compelling work on the biosynthesis of long-chain Nacylarylalkylamines (of which N-acyldopamines are a member) using an
endogenous recombinant N-acyltransferase from Fruit flies. (71) Dempsey and
colleagues’ work shows the likelihood that (a) an acyltransferase is indeed a major
part of the biosynthesis for these molecules and (b) previously unknown fatty acid
derivatives are still being discovered, such as the N-acylserotonin described.
Continued work such as this emphasizes the complexity of the
endocannabinoid metabolome and implies the richness of this area for further
therapeutic research. The possibilities that these various endocannabinoids may
help treat illnesses such as Alzheimer’s, Parkinson’s, pain, anxiety, depression and
even appetite implies a whole new realm of potential pharmaceuticals.
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CHAPTER 2:
THE DETECTION AND QUANTIFICATION OF ENDOGENOUS
ENDOCANNABINOIDS/FATTY ACID AMIDES IN A. MELLIFERA
(HONEYBEES) AND T. CASTANEUM (RED FLOUR BEETLES)

2.1

Introduction and Background
The common honeybee (Apis mellifera, Lat. “honey-bearing bee”) and the

red flour beetle (T. castaneum) are widely considered the most beneficial and most
destructive cosmopolitan pests in the modern world, respectively. The honeybee is
the primary commercial pollinator in modern agriculture, as well as producing
agricultural products like honey and bee’s wax. (1, 2) The red flour beetle, on the
other hand, consumes up to a quarter of grain crops in the western world alone and
is considered one of the most destructive pests in agriculture. (3, 4, 5)
As a result, extensive research has occurred over many years with regards
to the roles of these two diametrically opposed insects in the modern world.
Starting in the 1990’s the phenomenon known as “sudden colony collapse” began a
pattern of wide-spread loss of commercialized honeybees and crops, resulting in
low supplies and increasingly high costs for honey and those crops requiring
pollination. (6, 7) Grain crop losses from the red flour beetle, and its close relative
the Confused Beetle (Tribolium confusum) have been estimated as high as 50% of
total global seasonal yield. (8)
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For honeybees, the impact of the extensive loss of colonies worldwide is an
agricultural and commercial issue that cannot be adequately stressed within our
society. In the event of global catastrophic colony losses for this species a
cascading effect would result, causing not only massive agricultural and economic
devastation but also potentially worldwide famine. Such effects could result in the
deaths of millions. The current theory for the cause of sudden colony collapse is the
extensive use of pesticides, which likely causes massive die-back within colonies
including the queen. (2, 6) The mechanism for die-back events from pesticide
usage is still unclear and hotly debated. Current speculation suggests that
pesticides may be inhibiting or degrading the honeybee’s individual sensory
perception and/or the chemical signaling process between colony-mates via the
specie’s use of communal pheromonal communication.
In the context of the red flour beetle, conventional pesticides are inadequate
in controlling the species and any compounds that do are highly toxic upon
consumption of the treated crops. (9, 10, 11) Increases in pesticide usage have
several severe environmental and health effects, while showing little results in
controlling this pest species. A major concern is that as population density
increases and global temperatures further rise controlling the species will become
much more difficult and could result in even higher crop losses, especially in
economically and technologically depressed regions. As a result, much like
honeybees, wide-spread famine could ensue causing the deaths of millions and
creating a devastating cascade effect worldwide in terms of economics, agriculture
and possibly even lead to political strife.
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Red flour beetle’s increasing resistance to pesticides is likely due to uneven
distribution, concentration and exposure. (9, 11, 10) Therefore, it is clear that both
safer and more effective forms of control are needed to combat red flour beetles
while limiting the potential hazards of pesticide use against honeybees. Because of
the importance in pheromone signaling in communal organisms like honeybees, and
the recent discovery of endocannabinoids and TRP ion channels tied to sensory
perception

present

within

fruit

flies,

further

research

into

the

role

of

endocannabinoids may prove highly relevant. (12, 13)
Honeybees present a unique constraint for research however, due in part to
the inability to completely contain and control them in a laboratory environment, as
honeybees require the constant ability to forage in the environment or the colony
would perish. (14) As such, several unknown factors that cannot be easily
documented and quantified can readily affect the organism and corresponding
results. While their food supply can be supplemented, it cannot be completely
controlled; therefore traditional feeding studies are not feasible. The lifecycle and
life stages of honeybees are also difficult to control and monitor within the certainty
accustomed to model organisms. Red flour beetles, however, are easily cultured,
controlled and manipulated in a laboratory setting and have proven to be an
excellent model organism. (15)
In

2001,

however,

McPartland

and

colleagues

suggested

that

endocannabinoids do not exist in insects. (16) In contrast however recent work by
Jeffries, et al., have shown otherwise. (12, 17)

The need for additional model

organisms for continued studies in endocannabinoids were made even more
relevant in insects due to the full genome sequencing of both honeybees in 2006
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(18) and in red flour beetles in 2009. (3) As such genomic studies for the
endocannabic receptors and posited biosynthetic enzymes have shown significant
sequence homology within these insects between higher order animal species. (17)
Some of these key genomic similarities in the context of endocannabinoid
metabolism include the existence of an arylalkylamine N-acyltransferase (AANAT)
enzyme recently characterized from fruit flies showing significant homology with
similar enzymes in both honeybees and red flour beetles (Fig 2.1). (17)
Due in part to the research recently conducted in Fruit flies on the
biosynthetic enzyme AANAT, and the sequence homology described herein, the
usage of honeybees and red flour beetles to further elucidate the role, biosynthesis
and degradation of endocannabinoids/fatty acid amides is clear.
Prior to any possible studies involving the AANAT-like enzymes present within
these organisms it is first necessary to determine the endogenous identities and
concentrations

of

the

endocannabinoids/fatty

acid

amides

present.

Several

procedures to accomplish this have been developed over the years by various
groups, in organisms ranging from C. elegans, rats and mice, to cultured cells and
human tissue. (19, 20, 21) Much of these methods are only feasible with the use of
separation and spectroscopic techniques such as GC/LC/MS. These techniques are
not with limitations however, especially with lipid molecules such as the eCBs/FAAs,
and

include

oxidation,

over-fragmentation,

matrix

effects

and

column

contamination, to name a few. (22, 23, 24)
Key limitations

to note

include

inherent error with a shared mass

spectroscopy instrument and chromatography column such as cross-contamination,
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column degradation and contamination by known labware slip additives Oleamide
and Palmitamide (25, 26). A significant limitation of note is the oxidation of Nacyldopamines into the N-acyldopamine quinone/indole specie’s and has greatly
contributed to the elusiveness of detecting these specific molecules endogenously.
These reactions are widely documented and difficult to mitigate. Reasons for this
difficulty are due to sample treatment and exposure to oxidative environments,
such as air and light, that cause precipitation into di- and tri-polymers similar to
melanin which are resistant to mass spectroscopy techniques (Figure 2.2). For
additional information please refer to the review by D’Ischia, et al. (22, 27)
Despite these limitations herein is presented research into the detection and
quantification of a set of endocannabinoids/fatty acid amides (Table 2.1) from A.
mellifera and T. castaneum via high performance liquid chromatography quadropole
time of flight mass spectroscopy techniques (HPLC/QTOF-MS) along with genetic
comparisons of the Fruit Fly arylalkylamine N-acyltransferase (AANAT) between
these organisms.
Also presented herein is a proposed biosynthetic route to the eCBs/fatty acid
amides in light of the results shown and suggestions for further research. Overall,
this research provides additional evidence that endocannabinoids and fatty acid
amides are endogenous to these two organisms, despite the known cannabinoid
receptors showing no known expression in insects. In conjunction with the recent
data from Fruit flies (12) such mounting results demand additional questions as to
the nature of these compounds and the possibility of heretofore unknown
cannabinoid-like receptors.
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Figure 2.1. AANAT Sequence Homology Between D. melanogaster, A. mellifera and T. castaneum.
From NCBI BLASTp database.
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Figure 2.2: Select routes of N-acyldopamine oxidation to quinone/indole
intermediates and final di- and tri-mer products. R represents the long-chain fatty
acyl moiety. Based on chemistry as described by D’Ischia (22)
2.2

Experimental Methods and Procedures
All materials and chemicals used herein were acquired from Sigma-Aldrich,

Co. or Fisher Scientific unless otherwise noted. All fatty acid amide standards were
purchased from Caymen Chemical, Co.

2.2.a.

A. mellifera (honeybee) Acquisition and Processing
Honeybees were donated by the USF Botanical Gardens in cooperation with

Dr. Brent Weisman (USF Department of Anthropology). Two separate batches of
honeybees were acquired from the botanical gardens. The first batch, labeled as
“Farmed”, was obtained in late Fall 2013 and comprised approximately of 500 adult
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female worker bees (50 grams total mass). The second batch, labeled “Feral”, was
acquired by Dr. Weisman from a local rogue colony approximately 15-20 miles from
USF-Tampa campus. The feral bees comprised of approximately 200 adult female
workers (20 grams total weight).
Table 2.1: Select endocannabinoids/fatty acid amides to be identified and quantified
in A. mellifera and T. castaneum within this study

Compound

Abbreviation Molecular Formula

N- Oleoylethanolamine
N- Arachidonoylethanolamine

OEA
AEA

C20H39NO2
C22H37NO2

N- Palmitoyldopamine
N-Palmitoyldopamine Quinone

NPD
NPDq

C24H41NO3
C 24 H 39 NO 4

N- Oleoyldopamine
N-Oleoyldopamine Quinone

NOD
NODq

C26H43NO3
C 26 H 41 NO 4

N- Arachidonoyldopamine
N-Arachidonoyldopamine Quinone

NAD
NADq

C28H41NO3
C 28 H 39 NO 4

N- Oleoylserotonin
N-Oleoylserotonin Oxid Prod

NOS
NOSq

C28H44N2O2
C 28 H 44 N 2 O 3

N -Palmitoylglycine
N- Oleoylglycine
N- Arachidonoylglycine

NPG
NOG
NAG

C18H35NO3
C20H37NO3
C22H35NO3

Linoleamide
Palmitoleamide
Palmitamide
Oleamide

LOA
POA
PA
OA

C18H33NO
C16H33NO
C16H31NO
C18H35NO

Upon immediate acquisition of both batches all samples were placed on dry
ice for transport to the lab facility for processing. Processing of these samples
included full immobilization of the organisms in dry ice for 5-10 minutes,
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transferred to deep freeze containers and weighed then flash frozen over liquid
nitrogen for 10-15 minutes. After samples were thoroughly frozen the containers
were tightly sealed and shaken vigorously for 5 minutes to break apart the
organisms into three separate body parts: head, thorax and abdomen. Incidentally,
this process also removed the legs, wings and antennae of the organism as well as
any loose pollen or other particulate matter, wherein this material would collect on
the wall of the container or settle to the bottom allowing easy separation from the
organism segments. These segments were then separated out, while on ice, into
individual deep freeze vials and weighed. Each vial of segments were then purged
with nitrogen for 5 minutes, sealed and labeled and then stored at -80° C until
needed.

2.2.b.

T. castaneum (red flour beetle) Acquisition and Processing
Two samples of red flour beetle GA-1 strain were donated by Dr. Susan

Brown of the Kansas State University Tribolium Genetics Program in early spring of
2014. These samples were taken from the existing colony where the full genome
was previously sequenced. The samples were shipped overnight in sealed plastic
bottles containing approximately 50-75 adult beetles on 5 grams of growth media
(organic wheat flour with 5% w/w brewer’s yeast).
Upon receipt of the shipment the containers were immediately inspected. No
pupil, larval or egg stages of the organism were detected. Both samples were
placed in two sterilized large mason jars with a wire mesh screen lid containing 10
grams each of freshly prepared growth media (9.5 g. of pre-sifted organic whole
wheat flash-frozen flour and 0.5 g. brewer’s yeast, % w/w). Each colony jar was
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then placed in an incubating oven at 35° C under ambient humidity conditions.
Documentation obtained from the KSU:TGP determined that these conditions were
optimal for obtaining a maximum amount of the organism in the least amount of
time necessary (15, 28). Under these conditions a single generation from eggs to
adults will occur within 21 days. Each colony jar was inspected at least twice a day
to maintain temperature and to determine overall well-being of the colonies.
After approximately 2 weeks the colony jars were split, in which all adult
beetles were removed and placed into new jars with 10 g. fresh media. The
remaining jars, which now contain eggs and newly hatched larvae, are also
maintained at 35° C under ambient humidity conditions and closely monitored. This
cycle was repeated one additional time to produce 8 individual colony jars of either
adults (4 jars) or eggs/larvae (4 jars) comprising 3 distinct generations. With a
stable colony now established 2 of the adult colony jars were processed. All adult
beetles were removed after egg-laying and larvae development was verified, placed
into deep freeze vials and weighed then flash frozen over liquid nitrogen for 5
minutes. These vials were then purged with nitrogen, sealed and labeled then
placed under storage at -80° C until needed. Two jars of adults yield approximately
2.5-3 g. total weight (or ~250-300 beetles).

2.2.c.

General Extraction Method
The extraction and purification methods used for both organisms were

previously or concurrently described by Farrell, et al., (21) Folch, et al., (29)
Jeffries, et al., (12) and Sultana and Johnson (30), with only slight modifications.
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For the honeybees Apis mellifera, both farmed and feral, samples of each
segment (2.5 g. heads, 5.0 g. thorax and 10.0 g. abdomen) were taken and placed
in a mortar and pestle over ice with 1-5 g. clean sand and 1-5 mL of HPLC grade
methanol. The sample was then ground into a uniform paste, diluted with additional
methanol, allowed to settle from the sand and the remaining solution separated
into centrifuge vials. This solution containing ground organism segment suspended
in 10-15 mL of methanol was then placed on ice and ultra-sonicated for 20 minutes
in 1 minute on/off cycles to further rupture and homogenize cellular material for a
more extensive extraction. After sonication the solution was then briefly vortexed
for 1 minute then centrifuged at ~10000xG for 5 minutes. The supernatant was
then placed into large glass test tubes, capped with rubber stoppers, wrapped in
aluminium foil and set aside. The remaining pellet was then re-suspended in 10-15
mL of 1:1:0.1 of methanol:chloroform:water, ultra-sonicated on ice for an
additional 10 minutes, briefly vortexed for 1 minute and centrifuged for 5 minutes.
This secondary supernatant was then added to the first supernatant and set aside.
The

remaining

pellet

was

re-suspended

again

using

5-10

mL.

of

a

2:1

methanol:chloroform mixture containing 0.07 M KCl/0.11 M H3PO4 (stock 0.5 M
KCl/0.8 M H3PO4), further ultra-sonicated on ice for 5 minutes, briefly vortexed for
2 minutes and centrifuged for 10 minutes. The sample separated into three distinct
layers: the bottom organic layer, a middle highly viscous interphase layer
containing cellular material, and a top aqueous layer. The bottom organic layer was
separated and added to the first two supernatant layers. All three layers, now
combined, were dried overnight (~10-15 hours) under a steady stream of nitrogen.
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The remaining residue under nitrogen was then either stored at -80° C until needed
or immediately re-dissolved in 200 ul of N-hexane for subsequent purification.
For the red flour beetles the same extraction method was used with only 2.5
grams total of the whole organism.

2.2.d.

General Purification Method
The resultant residue from the extraction process is relatively crude and

requires solid-phase extraction prior to any further analyses.
A small 10 mL. glass solid-phase extraction column with a porous frit was
prepared using 0.5 g. of silica and a sand cap. This silica plug column was then
rinsed with 2-3 mL of N-hexanes in preparation for the addition of the crude
sample. The crude sample, re-dissolved in 200 ul. of N-hexane, was now carefully
added to the sand bed and allowed to settle into the silica before addition of any
further solvent. The crude sample was then washed and extracted using a mobile
phase solvent gradient comprising of 4 mL. N-hexane, 1 mL (v/v) each of 99:1
hexane:acetic acid, 90:10 hexane:ethyl acetate, 80:20 hexane:ethyl acetate, 70:30
hexane:ethyl acetate, 2.0 mL of 2:1 chloroform:isopropanol and finally 1 mL. of
methanol. Each gradient was collected separately in glass test tubes, capped and
dried under nitrogen. The 70:30 hexane:ethyl acetate, cholorform:isopropanol and
methanol fractions containing the extracted fatty acid amides were combined prior
to drying. Each fraction sample was then stored under nitrogen at -80° C until
further analysis. A total of 7 organism/body segments were used for the purification
and extraction process: Farmed honeybee heads, thorax and abdomen; feral
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honeybee heads, thorax and abdomen and whole-body red flour beetles. Each of
these samples were extracted and purified individually and separately.

2.2.e.

Preparation of Standards/Standard Curves and Blanks for Carry-Over and
Slip Additives
Standard molecules were grouped into 5 groups: acyl-dopamines, acyl-

glycines, acyl-serotonin, primary fatty acid amides and the internal standard D8-Narachidonoylglycine. The saturated/unsaturated N-acyl moiety lengths varied from
C16 (palmitoyl), C18 (oleoyl, linoleoyl), and C20 (arachidonyl). Each compound was
initially individually assayed to determine optimal concentration, retention times
and expected ion patterns. For the use as a standard molecule to mimic an
endogenous environment each compound was then combined into a dilution of 25
uM in 1 mL HPLC-grade methanol (62.5 ug/mL, 0.025 nmoles on-column injection),
including the internal standard. All standards were assayed in triplicate with
retention time deviations less than 0.2 mins. prior to each assay elution profile for
all sample sets. (12)
For the purpose of standard curves used in quantitative analysis each
compound was serial diluted to the range of 0.025 – 0.25 nM (0.0025-0.025
nmoles injected on column). This range was determined to be the linear dynamic
range of detection, with the lower limit being approximately 0.00125 nmoles
injected on column due to significant scattering and the upper limit greater than
0.025 nmoles injected on column due to a non-linear response curve. Additionally,
each sample used for standard curve production included 0.025 nM of the internal
standard to correct for any instrument and day to day usage deviations. Standard
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curves for oleamide, palmitamide, palmitoleamide and linoleamide were done
previously and only the slope of the linear region was available.
Blanks for use in between HPLC-MS samples were prepared using 1.0 mL of
pure HPLC-grade methanol assayed in triplicate. Sample blanks were also used
prior to and after all assays were completed to flush the HPLC-MS system. To
compensate for the presence of the slip additives oleamide and palmitamide 10 mL
of HPLC-grade methanol was used in the same procedure as the extraction and
purification method described herein, with 10 uL of the final concentrated sample
diluted into 1 mL for HPLC analysis after the completion of all other assays.

2.2.f.

HPLC-QTOF-MS and MS/MS Sample Analysis
In preparation for analysis via mass spectroscopy each fraction was re-

dissolved in 100 µl. of HPLC methanol, from which 10 µl was then diluted into 1 mL.
total of methanol spiked with 25 µm of the internal standard N-arachidonoylglycined8 (1.50 µl at 170 µm). This internal standard was used to monitor and normalize
instrument deviation in tandem with a calibration sample of only the internal
standard assayed prior to all analyses. Additionally, a sample mixture of standard
molecules at 25 µm in 1 mL. of methanol was also prepared and used during all
sample analyses. Each organism/body segment sample is injected and analyzed 4
times and is considered an endogenous sample set. Therefore, a total of 18 unique
sample sets were used from farmed honeybees (5 heads, 7 abdomen, and 6
thorax), 20 unique sample sets for feral honeybees (12 heads, 4 each abdomen and
thorax) and 5 unique sample sets of red flour beetles (whole body). In total, data
acquisition for the detection and quantification of endogenous fatty acid amides
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produced about 200 individual data files from the organisms alone, not including
standards, standard curve production, blanks and previous extractions and
purification sample assays that did not yield results. Additionally, a sample of A.
mellifera thorax extract was spiked with 25 pmols of pure standard mixture to
determine extract matrix effects on retention time deviations and detection.
All sample analyses were performed on an Agilent 1260 HPLC system fitted
with a Kinetex reverse-phase column (C18, 2.6 µm, 100 Å, 50 mm x 2.1 mm). The
mobile phase comprised a binary mixture of Solvent A and Solvent B (water and
acetonitrile, each with 0.1% formic acid, respectively) set to a linear gradient over
time. Three time segments of this elution profile gradient over a total of 11.5
minutes were programmed for all sample assays, with a 1 minute pre- and 2
minute post-assay system flush. Time segment 1 was from 1-5 minutes with a
linear increase of Solvent B from 10% to 100%. Time segment 2 was from 5-8
minutes with an isocratic mobile phase of Solvent B at 100%. Time segment 3,
from 8-9.5 minutes, returned the mobile phase to 10% of Solvent B. Flow rate
throughout the analysis time was 0.6 mL/min at ambient temperature with a
programmed pressure limit of 600 bar. Sample injection was 10 µl per sample with
a draw speed of 100 µL/min and an eject speed of 200 µL/min. A needle wash of 3
seconds with methanol was performed prior to sample injection into the HPLC
system.
All compounds of interest were determined to elute between 5 and 7
minutes. To minimize mass spectrometer source contamination only this 5-7 minute
portion of the analysis time was analyzed and recorded via MS. The remaining time
periods

were

diverted

to

waste

containment
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on

the

instrument

and

chromatographic responses were not recorded in the majority of the samples used
for quantitative analysis.
Mass spectrometric analysis of all samples was performed using an Agilent
6540 Quadropole Time-of-Flight Mass Spectrometer coupled to the HPLC system.
Ion source was a Dual Agilent Jet Stream Electrospray Ionization set to positive ion
mode. Additional system parameters are as follows: Nitrogen source gas, 100-3000
m/z range; 2.00 spectra/sec acquisition scan rate in extended dynamic range mode
(2 GHz); 300° C. gas temperature; 8.0 l/min. gas flow rate; 35 psig nebulizer
pressure; 350° C. sheath gas temperature; 11 l/min. sheath gas flow rate; 3500
Vcap; 1000 V nozzle voltage; 175 V fragmentor and 65 V skimmer. Internal
reference samples inherent to any analysis performed with this instrument occurred
at +121.05087300 and +922.00979800 m/z. System calibration and auto-tuning
was performed prior to any and all analysis.
For the purpose of confirming the presence of endogenous eCBs both AEA
and OEA standards, and both A. mellifera and T. castaneum extracts, were used for
targeted tandem mass spec-mass spec product ion analysis. Each sample was
prepared as previously described herein. Pure standard of AEA was used to
determine the optimal collision energy for product ion fragmentation and the
retention time prior to determining the endogenous presence of AEA in both
organism extract samples. Optimal collision energy was experimentally determined
to be 25 eV, with testing also performed at 15 eV for AEA, and retention times of
approximately 5.6 and 6.0 minutes for AEA and OEA, respectively. OEA was spiked
into

both

organism

extract

samples

to

determine

assay

functionality

and

confirmation of the retention time within each extraction matrix. Only the
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endogenous AEA was assayed in A. mellifera thorax and T. castaneum whole body
extracts. Parent-to-product ion fragmentation of AEA was m/z 349.18
for OEA m/z 324.98

62.06 and

62.06.

Prior to sample assays and after completing all assay elutions a column flush
program was used to remove any contamination, standard molecule carry-over and
slip additives from the column. This program consisted of the previously described
method herein using an extended solvent linear gradient and isocratic period
totaling 20 minutes (10 minutes each), with all solvent elution diverted to waste.
This flushing program was performed in duplicate.

2.2.g.

Sample Data Analysis – Qualitative Identification
Each sample injection produced a Total Ion Count (TIC) chromatogram,

showing the full response of all detected ions within the 100-3000 m/z range for
the recorded time period, as an individual data file with an appropriate name to
reflect the organism/body segment, date and replication number. These individual
files were then analyzed using Agilent MassHunter qualitative analysis v. B. 05.00
software.
All analyzed endogenous samples were compared to both the chromatogram
retention times and mass spectrometer ion results of known pure standards
acquired from Caymen Chemicals, Inc. assayed concurrently with each sample
series. Acceptable variances for comparisons in terms of retention time and m/z
were determined to be ±0.2 minutes and ±25.0 m/z. Additionally, dopamine and
serotonin derivatives are known to produce oxidized compounds in solution and in
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contact with atmosphere. These quinones should also be determined and, if any are
detected, added to the total amount of the reduced form of the molecule.
Endogenous determination of each molecule was determined using the
following

method

with

the

Agilent

MassHunter

software,

based

on

initial

determinations from the first set of standards using procedures contained within
the software, optimized based on greater usage and understanding of the software
and principles of mass spectroscopy.
After executing each sample injection data file the molecular formula for the
respective molecule of interest was input into the Find by Formula- Options tab
located under the Find Compounds by Formula section of the Methods Explorer
menu. The Matches per Formula option was set to 3, with the option to match for
isomeric compounds turned on. Match tolerances were set to ±100 ppm masses
and ±0.35 retention time. Expansion of values for chromatographic extraction was
set to systemic ±35.0 ppm with limited EIC extraction range left to default values.
The expansion values were varied as needed to obtain optimal results as
determined by the known standard analysis as this often varied by molecule.
Positive ions were set to H+ and Na+ only. Settings under the Results tab were left
to default values, ensuring that Extract EIC and Extract clean spectrum are marked
as on. Under the Results Filter tab all options were marked off except the option to
only match formulas to generated compounds. After confirmation of these options
the operation was executed by selecting all of the relevant samples in the
subsequent menu. The results produced is the individual Extracted Ion Count
chromatograms (EIC), a sortable table of the EICs showing the area of the peak(s)
for the compound with retention times, and various other values, with a
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corresponding mass spectrogram showing the ion and isotope distribution for each
EIC. The table is then sorted by retention time, highlighting the standards used,
and any EICs listed outside of the acceptable variance are removed. In the event
that the standards produce multiple EICs of various retention times only those EICs
with similar retention times to the original standard sets assayed, and those with
the expected higher peak areas, were used with all others disregarded. These
disregarded results for the standards are considered on-column contaminants
and/or

molecules

similar

enough

to

match

the

given

formula

within

the

programmed tolerances. The remaining EICs and mass spectrograms are then
compared to the standard. Ion and isotope abundance are compared in the context
of the acceptable tolerances set as well as the overall “spread” of the isotopic ion
abundance. Systemic variances of these spectrograms are endemic to this process
due to the overall crude and complex nature of the endogenous samples as well as
the oxidation of some of these molecules. (12, 22, and 31). Further details will be
discussed in later sections below. As an additional cross-reference between
potential endogenous samples and the standards a comparison of the target massto-charge ratio difference should also be taken into account. Finally, the software
also outputs a Score value which takes into account several variables including
target m/z differences, predicted ion masses and isotopic abundance pattern. Due
to these parameters, this value is highly dependent upon sample purity and
concentration and should not be readily considered for determination of compound
identification. However, a high Score value, in conjunction with an acceptable
retention time as compared to the standard, does not necessarily detract from a
positive identification of a compound. (12)
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After a sample series is identified as an endogenous compound the file is
then saved as a tab delimited Excel file from the Export option ensuring that
retention time and peak area are stored. This file can then be copy and pasted into
an existing Excel file for further data analysis and calculations.

2.2.h.

Sample Data Analysis – Quantitative Analysis
After qualitative identification of the sample series is complete and all

relevant data is stored and sorted, the area for each compound determined is then
calculated into a corresponding endogenous amount within the organism/body
segment.
For each sample series confirmation of the internal standard of Narachidonoylglycine-d8 must be determined prior to any quantitative analysis as
well as a compound’s corresponding standard curve. Each endogenous sample
series average area of the curve must be adjusted using the internal standard
average area of the curve present in the sample series with a pure sample injection
of the internal standard. First, the average area of the curve for the internal
standard co-injected with the endogenous sample is weighted against an injection
assay of the pure internal standard prior to any endogenous samples for that day’s
analyses. This ratio of pure internal standard to co-injected I.S. is then multiplied
into the average and standard deviations of all endogenous compound area of the
curves. This is done to compensate for day-to-day instrument deviations, potential
changes in column conditions and other similar variables such as solvent changes,
variances in temperature, etc. For any oxidation products detected in the acyl
dopamine series the area of the curve for the quinones are added to the area of the
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reduced molecule prior to this correction, though are generally negligible when
detected.
The compensated averages and standard deviations are then calculated into
corresponding pmol/gram amounts using the slope of a standard curve for the
corresponding compound. This calculation is determined prior to any analysis and is
a series of stoichiometric conversions using the amount of the sample diluted for
injection, the total volume diluted into, the calculated amount delivered to the
column, the amount of the organism/body segment used for the sample and finally
the slope of the standard curve. In general mathematical principles, all of these
calculations can be summed into one value that is then divided by the slope and
multiplied by the corrected average of the area of the curve for the endogenous
compound. (12, 17, 21) This calculation is repeated for the standard deviation as
well. Both values are in pmol/gram of organism. Care must be taken to ensure that
these calculations are correct. An example of a data set and the calculation process
is shown in Figure 2.3 below.
Finally, after each sample series is calculated into an average pmol/gram ±
S.D. value these averages are further averaged together based on the total number
of sample series’ assayed, with any on-column contamination amounts subtracted
out using the same methods applied to the corresponding blanks assayed in
between each sample series. The resultant aggregate average and standard
deviation now reflects the final endogenous amounts of the corresponding
compound detected.
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Figure 2.3: Example data set taken directly from results file (OEA, Tribolium) and
an example calculation for the quantitative analysis of OEA used for all endogenous
endocannabinoids/fatty acid amides. This same calculation is used for the standard
deviation of pmol/gram and for the carry-over/contamination amounts if detected,
which are subtracted from the average pmol/gram.
2.2.i.

Sequence Homology with D. melanogaster AANAT
Expression of fatty acid amides endogenous to A. mellifera and T. castaneum

requires the existence of arylalkylamine N-acyltransferases (AANATs) such as those
previously determined within Drosophila melanogaster. (17) Utilizing the NCBI
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database

(http://www.ncbi.nlm.nih.gov/),

sequence

homology

comparisons

between the known D. melanogaster NAT CG9486 (NP_609005.1) with possible
NATs in both A. mellifera (taxid: 7460) and T. castaneum (taxid:7070). An online
protein BLASTp sequence analysis using the NCBI database software of CG9486
with these organisms produce homology sequences with two isoforms of dopamine
N-acetyltransferases in both organisms, NP_001139380.1 and NP_001139379.1
(Tribolium isoforms 1 and 2, respectively); XP_392876.2 and XP_006566050.1 (A.
mellifera isoformX1 and X2, respectively). All sequence comparisons showed
greater than 30% identity with coverage greater than 93%. Additionally, sequence
comparison of protein residues was also performed showing conserved residues
between all three organisms. (17) MEME motif studies were conducted by uploading
the

above

amino

acid

sequences

into

the

MEME

tool

located

at

http://meme.nbcr.net/meme/ and exporting as an htmL document.

2.3
2.3.a.

Results and Discussion
Standard Samples, Standard Curves and Spiked Standards in Apis
mellifera Thorax
The N-acylated derivatives of ethanolamines (NAEs), dopamines (NADs),

serotonin (NOSt), glycines (NOGly) and primary fatty acid amides (PFAAs)
investigated in this study are summarized in Table 2.2 above. Stated retention time
is the average from all standard mixes assayed concurrently with each sample
series, including any oxidation side-products when detected. Assays of individual
separate standards is not shown, as these were not indicative of the molecules
within the endogenous sample series tested due to matrix effects (dynamic sample
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mixture, solvent effects, precipitation, etc.) and other uncontrollable and unknown
conditions.
Table 2.2. Summary of standard molecules used. Included is the abbreviated name,
average retention time ±0.2 minutes, mass-to-charge ratio of the proton and
sodium adducts and the molecular formula. Also included are the known possible
oxidation products, when applicable.

N.D. is not detected with adequate reproducibility
Only the standards as a total mix were used to best mimic the complex
matrix environment of the endogenous samples. The stated mass-to-charge ratios
are that for the protonated ionized parent molecule, [M+H]+, and that of the
sodium adduct of the ionized parent molecule, [M+Na]+, respectively. These values
are derived directly from the standards of these molecules as observed.
Construction of the standard curves proceeded as previously described.
Examples of these standard curves, and the corresponding mass spectral results,
are presented below for the internal standard D8-NAG (Fig. 2.4). All other standard
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curves and mass spectral results are presented in the appendix of this chapter.
Documented retention times for each standard sample shown are within the
aforementioned ±0.2 minute tolerance, with the average retention time for each
compound labeled within the graph. Percent error of the standard curves is less
than 5% for each data point shown. X-axis intercept values are not shown as each
sample gave values less than 10% of the calculated slope and thus would calculate
outside of the acceptable limits of significant figures. Calculated slope values shown
all provided R2 linearity values >0.95. Mass-to-charge ratio values for both proton
and sodium adducts are within 25 ppm of the expected values per those calculated
via the software. The presence of oxidation products in the N-acyldopamine series
is also compensated for, as previously discussed in the methods portion.
Standard curves for the primary fatty acid amides are not shown and slope
values were provided by Jeffries, et al., (12) using the same assay methods, stock
samples and column. Only the individually-assayed standards are provided
(Appendices).
In an effort to control for matrix effects, cellular oxidation and other variables
due to assaying relatively impure and highly complex mixtures from these
organisms, a brief series of controlled spiked samples were performed (OEA
example, Figure 2.5). Two sample sets of farmed A. mellifera thorax were
extracted and purified with the addition of known amounts of OEA, AEA, NAD and
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NOG added at the beginning of the extraction process. An additional sample series
included these compounds just prior to purification only. Each set was assayed as
described previously then compared to the standard mix of these compounds that
were concurrently assayed. Only the samples spiked prior to extraction is shown,
as the samples spiked prior to purification did not complete the assay process
correctly (data not shown), likely due to high concentrations saturating instrument
detection or instrument error and time constraints.

Side-by-side comparisons of

the spiked samples with the standard mix clearly shows a pattern of retention time
deviation within the acceptable tolerance of ±0.2 minutes, likely due to the
aforementioned matrix effects, instrument variation and column conditions.
Additionally, these results also show changes in the detected m/z values and the
changes on ion distributions, likely a result of decreased concentration directly
affecting instrument analysis and computation of those values. Such errors and
limitations were proven to be highly pervasive within the entirety of the data
collected. Suggestions for the mitigation or elimination of these errors include use
of a column in better condition and more extensive sample clean-up prior to
assaying. Column/instrument contamination and compound cross-over of previous
samples also occurred, likely also due to the complex nature of the extracted
samples and instrument limitations
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Figure 2.4. Example Standard Curve and MS results for D8-NAG I.S.
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Figure 2.5. Spiked OEA in A. mellifera thorax showing sample matrix effects, instrument deviation and
column condition on retention time and m/z variation (Left: standard OEA, Right: aggregate spiked
thorax).
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2.3.b.

Endogenous Results – Farmed and Feral A. mellifera

Table 2.3. Summary of quantitative results for eCBS/FAAs in farmed A. mellifera.
Amounts are reported as average ± S.D in pmol/g. of organism from 20 individual
assays of heads, 28 from thorax and 24 from abdomen.
Farmed A.M. (pmol/g)
Molecule
Heads
Thorax
Abdomen
N- Oleoylethanolamine
N- Arachidonoylethanolamine

30 ± 8
41 ± 3.0

6±7
6±5

437 ± 122
10 ± 6

N- Palmitoyldopamine
N- Oleoyldopamine
N- Arachidonoyldopamine

4 ± 0.5
*
*

11 ± 9
19 ± 6
*

26 ± 10
28 ± 9
*

N -Palmitoylglycine
N- Oleoylglycine
N- Arachidonoylglycine

125 ± 41
31 ± 1
25 ± 3

16 ± 9
6±2
14 ± 3

52 ± 18
4±2
3±1

N- Oleoylserotonin

*

*

*

Linoleamide
Palmitoleamide
Palmitamide
Oleamide

0.2 ± 0.5
143 ± 200
17 ± 5
179 ± 43

11 ± 6
114 ± 83
12 ± 5
51 ± 15

44 ± 15
356 ± 288
20 ± 13
85 ± 37

*Compound not detected with adequate reproducibility
Table 2.4. Summary of quantitative results for eCBs/FAAs in feral A. mellifera.
Amounts are reported as average ± S.D in pmol/g. of organism from 48 individual
assays of heads and 16 each from thorax and abdomen.
Feral A.M. (pmol/g)
Thorax
Abdomen

Molecule

Heads

N- Oleoylethanolamine
N- Arachidonoylethanolamine

35 ± 16
27 ± 18

31 ± 16
17 ± 9

1918 ± 110
*

N- Palmitoyldopamine
N- Oleoyldopamine
N- Arachidonoyldopamine

76 ± 29
46 ± 24
*

20 ± 21
*
*

140 ± 6
*
*

N -Palmitoylglycine
N- Oleoylglycine
N- Arachidonoylglycine

36 ± 29
32 ± 4
12 ± 7

50 ± 29
18 ± 14
*

220 ± 72
32 ± 14
21 ± 9

N- Oleoylserotonin

45 ± 26

59 ± 38

362 ± 170

Linoleamide
Palmitoleamide
Palmitamide
Oleamide

45 ± 21
398 ± 141
127 ± 19
163 ± 57

24 ± 25
911 ± 389
13 ± 6
948 ± 634

153 ± 39
1423 ± 639
80 ± 12
438 ± 164

*Compound not detected with adequate reproducibility
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Samples for the detection of the endogenous eCB/FAAs proceeded as
previously described with the awareness of the aforementioned limitations observed
with the standards and spiked assays. Sample reproduction yielding results within
acceptable values was difficult to acquire and is again likely due to the
aforementioned limitations. Attempts at mitigating these errors and limitations
provided limited success. The total number of assayed samples for the entirety of
this study was prohibitively high (>200) considering the nature and preparation of
the samples and the instruments used.
For clarity, the aggregate of all body segments from farmed A. mellifera is
shown as an overlapping spectrum per each compound, with select mass spectral
results shown also for clarity. All utilized data was comparable however for detected
molecules. Several examples are shown in Figures 2.6-2.8, with the remaining
supplied in the appendix of this chapter.
Reproducible results, or sufficient results to provide a statistically acceptable
value, were unobtainable for NAD in all body segments for both farmed and feral A.
mellifera. Any detected results were likely due to anandamide “shadow” peaks.
Therefore, the endogenous detection of this compound is inconclusive in both
groups of this organism. It is unlikely that the similarity of these results is due to
direct environmental or genetic differences between the two groups; rather it is
more likely that NAD exists below the detectable threshold of the assay technique
and instrument. Overall concentration of NAD within each organism may vary due
to unknown factors at the time of collection. An example of such a variable may be
body temperature, as it has been speculated that NAD may be part of body
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temperature regulation in other animals, though no evidence to date thus far
suggests this is the case in insects. Another factor is that NAD in low endogenous
concentrations may have readily oxidized to the quinone/indole forms, aggregated
and precipitated out either during the extraction and purification process or prior to
assaying of the diluted samples, thus preventing reliable and reproducible detection
by mass spectroscopy. Without a reliable method of measuring and quantifying this
oxidation phenomenon overcoming this limitation using these techniques is difficult
at best. One method that could provide quantifiable results would be the use of an
oxidizing agent such as sodium periodic acid with known amounts of heavy-labeled
compounds in vitro then analyzed via mass spectroscopy. (22) However, periodic
acid usage in HPLC-MS systems is generally unacceptable do to damaging the
instrument.
NOSt was undetected in all three farmed body segments, unlike in the feral
body segments as presented in Table 2.4. The reasons for this discrepancy is
similar to those discussed for NAD, though the nature and function of NOSt is
currently unknown in insects and may or may not be related to direct
environmental or biological factors, such as body temperature regulation as posited
for NAD. Serotonin is known to be a digestive system signaling and mediation
neurotransmitter in higher animals, such as mammals, and has only very recently
been determined to have similar roles in A. mellifera. (32) Since the highest
detected levels of NOSt from this study is in the abdomen (362 ± 170 pmol/g),
such data is therefore plausible. Concurrently, Verhoeckx and colleagues have
detected endogenous levels of N-acylserotonin within mice and pigs primarily
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localized in the intestine. Their data suggests direct links to the endogenous levels
of these molecules with serotonin and a diet supplemented with fatty acids. (33)
Such research further sheds light, and lends strong evidence, to the currently
proposed

biosynthetic

and

degradation

pathways

having

been

mentioned,

specifically the direct conjugation of fatty acids to fatty acid amides and the
degradation/regulation via FAAH (Figs. 1.3-1.5). An additional source for this
discrepancy may also be the existence of microbiota within or on the feral
honeybees which may be contributing to these endogenous levels. Much of the
recent work with N-acylserotonins is providing very promising and exciting results
within the field of endocannabinoid research.
In general, a strict comparison of the endogenous levels of the remaining
compounds gives comparable results within an acceptable order of magnitude.
Much of the variations shown for many of these molecules can generally be
attributed to factors including variability in the extraction and purification process,
instrument variation, and unknown biological factors contributing to the expression
of these compounds in vivo. N-oleoyldopamine, however, in comparison between
farmed and feral A. mellifera does show discrepant results. Between farmed and
feral groups the overall detection of NOD in specific body segments is not
consistent. For farmed bees NOD is detected with sufficient reproducibility in thorax
and abdomen, while being absent or inconsistent in the heads. In contrast, the
opposite results occurred for the feral population. It is generally assumed such
discrepencies with N-acyldopamines specifically is due, at least in part, to their
predilection for oxidiation to polymeric structures which are difficult to detect and
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quantifiy. (22) Additionally, because of the inherently high deviations from the
methods employed such discrepancies in detection can be expected. Exceptions
would be any recurring patterns such as these occurring in other compounds
between the two populations. Indeed, these high deviations in detected levels are
higher than the average levels calculated. An example of this is the primary fatty
acid amides in both farmed and feral populations. As such it is debatable whether
these endogenous values are indeed valid. However, the PFAAs are generally
considered a separate class of molecules that have been extensively researched in
their own right and are tangentially related to the eCBs/FAAs in the scope of this
work. PFAAs presented herein are shown for the purpose of giving context and
broader

relevance

whilst

connecting

to

established

endogenous

molecules.

Additionally, specific PFAAs, such as Oleamide and Palmitamide, are known slipadditives in many laboratory plastic-ware and must be compensated for, as
described previously. (26, 25)
A final note on the quantification of the endogenous eCB/FAA levels using
standard curves are variations in the column and instrument over time between the
measurement of the standard curves and the measurement of the endogenous
levels. System response and column conditions are likely to change with extensive
usage, therefore a strict comparison of the response for standards with endogenous
levels over a separated period of time are increasingly likely to show deviation.
Generally speaking, standard curves should be repeated every three to six months,
depending on usage, to further compensate for such deviations. At the time of the
endogenous assays the provided standard curves were nearing the six month
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limitation. Repeating the standard curves was not possible due to lack of access to
the HPLC-QTOF/MS upon completion of the endogenous assays.
The determination of these compounds being truly endogenous to these
organisms would not be complete without a tandem mass spectroscopy assay. A
targeted MS/MS assay is employed to show the expected product ion fragmentation
from a given parent ion, such as [M+H]+. For this purpose, a targeted MS/MS
comparative study between standard anandamide, spiked OEA and endogenous
anandamide was conducted in A. mellifera thorax. Standard AEA was used to
determine the retention time (~5.6 minutes) and optimal fragmentation voltage
(25 eV) using the standard assay techniques described previously. OEA was used in
conjunction as a spiked standard for the same purpose and to observe any potential
deviations due to matrix effects, etc. (~6.0 minutes, 25 eV). Both compounds gave
the expected product ion fragment of m/z 62 corresponding to the ethanolamine
fragment (Fig. 2.9 and 2.10). The remaining fragments, long-chain aldehydes of
m/z 289.2 and 267.2 for AEA and OEA respectively, are likely either obscured
during detection by other background ions or exist as uncharged species. Though
not predicted, the fragment at m/z 287.2 may be this remainder existing as an
[M]+ species.
Though limited, these results are fairly indicative of the endogenous nature
of the eCBs/FAAs described within this study and provides some validation of these
results in the Apis mellifera species.
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Figure 2.6. Aggregate spectra and MS results of endogenous OEA and NPD in
farmed A. mellifera.
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Figure 2.7. Aggregate spectra and MS results of endogenous acyl glycine NPG and
Palmitamide in farmed A. mellifera.
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Figure 2.8. Aggregate spectra and MS of suspected endogenous N-oleoylserotonin
in both farmed and feral populations of A. mellifera.
.

69

O
N
H
Anandamide (AEA)
m/z [M+H]+: 348.28 (100.0%), 349.29 (24.3%), 350.29 (3.2%)

OH

O
+
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenal
m/z [M+H]+: 289.25 (100.0%), 290.25 (22.0%), 291.25 (2.5%)

H2N

OH

2-aminoethan-1-ol
m/z [M+H]+: 62.05 (100.0%),
63.06 (2.3%)

O
N
H
Anandamide (AEA)
m/z [M+H]+: 348.28 (100.0%), 349.29 (24.3%), 350.29 (3.2%)

O
+
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenal
m/z [M+H]+: 289.25 (100.0%), 290.25 (22.0%), 291.25 (2.5%)

H2N

OH

OH

2-aminoethan-1-ol
m/z [M+H]+: 62.05 (100.0%),
63.06 (2.3%)

Figure 2.9. Targeted MS/MS spectra of standard AEA at 15 eV collision energy
showing the absence of the expected product ion fragment, m/z 62.06. Targeted
MS/MS spectra of standard AEA at 25 eV collision energy showing the presence of
the expected primary product ion fragment, m/z 62.06 and corresponding decrease
in the parent ion, m/z 348.2. Inset shows the predicted fragmentation pattern for
AEA.
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Figure 2.10. Targeted MS/MS spectra of AEA in A. mellifera extract at 25 eV
collision energy showing the expected primary product ion fragment, m/z 62.06,
and targeted MS/MS spectra of spiked OEA in A. mellifera extract at 25 eV collision
energy showing the same expected product ion fragment. Inset shows the
predicted fragmentation pattern for AEA and OEA, respectively.
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2.3.c.

Endogenous Results – T. castaneum

Table 2.5. Summary of quantitative results for eCBs/FAAs in T. castaneum.
Amounts are reported as average ± S.D in pmol/g of organism from 20 individual
assays of whole bodies.
Molecule

Tribolium (pmol/g)
Whole Body

N- Oleoylethanolamine
N- Arachidonoylethanolamine

36 ± 8
42 ± 24

N- Palmitoyldopamine
N- Oleoyldopamine
N- Arachidonoyldopamine

53 ± 25
21 ± 6
26 ± 14

N -Palmitoylglycine
N- Oleoylglycine
N- Arachidonoylglycine

25 ± 12
16 ± 9
18 ± 17

N- Oleoylserotonin

*

Linoleamide
Palmitoleamide
Palmitamide
Oleamide

*
178 ± 83
53 ± 37
102 ± 45

*Compound not detected with adequate reproducibility
As for the honeybees, samples for the detection of the endogenous eCB/FAAs
in T. castaneum proceeded as previously described with the awareness of the
aforementioned limitations observed with the standards and spiked assays. Sample
reproduction yielding results within acceptable values was equally as challenging for
T. castaneum as it was for A. mellifera; again likely due to the aforementioned
limitations. Attempts at mitigating these errors and limitations provided limited
success for T. castaneum as well. The total number of assayed samples was also
prohibitively high (>30) considering the nature and preparation of the samples and
the instruments used, though not as high as compared to A. mellifera due to the
beetles being whole body extracts and not three separate segments.
For clarity, the aggregate of all assays for each molecule from T. castaneum
is shown as overlapping spectra, with select mass spectral results also shown for
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clarity. All utilized data was comparable however for detected molecules. Several
examples are shown in Figures 2.11-2.12, with the remaining supplied in the
appendix of this chapter.
Reproducible results, or sufficient results to provide a statistically acceptable
value, were unobtainable for NOSt in T. castaneum and is inconclusive for this
molecule. Like A. mellifera, it is unlikely that the inability to adequately detect and
quantify NOSt is due to any environmental or biological issue, but rather is likely
due to the endogenous levels existing below the detectability limit of the
instrument. Another potential factor, like that of NAD, is that NOSt in such low
endogenous concentrations may have readily oxidized to a form similar to the
quinones/indoles produced by N-acyldopamine oxidation. If so, NOSt may have
aggregated and precipitated out either during the extraction and purification
process or prior to assaying of the diluted samples, thus preventing reliable and
reproducible detection by mass spectroscopy. Similarly, without a reliable method
of measuring and quantifying this oxidation phenomenon overcoming this limitation
using these techniques is difficult at best. The suggested method as described for
the NAD, the use of periodic acid to induce oxidation of heavy-labeled compounds
in conjunction with HPLC-MS, is again generally unacceptable do to damaging the
instrument.
Additionally, the detected levels of NAG, 18 ± 17 pmol/g, suggests that this
compound may not exist endogenously, statistically-speaking. It is likely that NAG
does exist endogenously in comparison to A. mellifera and also by taking into
account that the detected value for NAG does not follow the observed trend in the
data for the other molecules present. The cause for such an outlier is suggested to
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be similar to the absence of NOSt, that being low endogenous levels existing below
the detection limit of the instrument in conjunction with various other limitations
aforementioned.
The data collected for Linoleamide was inconclusive due to any endogenous
values having been subtracted out when compensating for carry-over and/or the
existence of slip additive determined from control samples.
Unlike honeybees however, the presence of NAD is detected and measured in
the red flour beetles (26 ± 14 pmol/g). Such data may suggest that the levels of
NAD are higher in this organism than in A. mellifera for it to be at such a detectable
level.
In general, a strict comparison of the endogenous levels of all assayed
compounds gives comparable results within an acceptable order of magnitude, with
relatively low deviations in comparison to the results presented for A. mellifera.
Again, variations shown for many of these molecules can generally be attributed to
factors including variability in the extraction and purification process, instrument
variation, and unknown biological factors contributing to the expression of these
compounds in vivo.
It should be noted that the statistical variations of the data as a whole, with
the exceptions previously noted, is comparatively low to that of A. mellifera (and to
a lesser degree the results published for D. melanogaster by Jeffries, et al.). A
likely cause for these comparatively positive results to A. mellifera is that all assays
used to derive these values were conducted during the same assay session in a
relatively short time span (6-8 hours for Tribolium versus 12-14 hours for
Mellifera). In the context of the prior argument that the deviations of these values
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are in part due to possibly outdated standard curves, and to day-to-day instrument
variations, these results suggest that instrument variation has a greater impact.
As for A. mellifera, confirmation of the endogenous nature of these molecules
requires a targeted MS/MS assay. Similar to that performed for A. mellifera, spiked
OEA and endogenous AEA were studied using the aforementioned MS/MS technique
in Tribolium whole-body extract. Standard AEA was again used to determine the
retention time (~5.6 minutes) and optimal fragmentation voltage (25 eV) using the
standard assay technique. OEA was used as a spiked standard for the same
purpose and to observe any potential deviations due to matrix effects, etc. (~6.0
minutes, 25 eV). Both compounds gave the expected product ion fragment of m/z
62 corresponding to the ethanolamine fragment (Fig. 2.13). The remaining
fragments, again long-chain aldehydes of m/z 289.2 and 267.2 for AEA and OEA
respectively, are likely either obscured during detection by other background ions
or exist as uncharged species, just as in the A. mellifera MS/MS results. Also
similar to A. mellifera results, the fragment at m/z 287.2 may be this remainder
existing as an [M]+ species.
For T. castaneum, these results are fairly indicative of the endogenous
existence of the eCBs/FAAs described within this study and provides validation of
these results in the T. castaneum species.
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Figure 2.11. Aggregate spectra and MS of endogenous OEA and the acyl dopamine
NOD in T. castaneum.
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Figure 2.12. Aggregate spectra and MS of endogenous the N-acylglycine, NOG, and
of the PFAM Palmitamide in T. castaneum.
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O
N
H
Anandamide (AEA)
m/z [M+H]+: 348.28 (100.0%), 349.29 (24.3%), 350.29 (3.2%)

O
+
(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenal
m/z [M+H]+: 289.25 (100.0%), 290.25 (22.0%), 291.25 (2.5%)

H2N

OH

OH

2-aminoethan-1-ol
m/z [M+H]+: 62.05 (100.0%),
63.06 (2.3%)

Figure 2.13. Targeted MS/MS spectra of endogenous AEA in T. castaneum extract
at 25 eV collision energy showing the expected product ion fragment, m/z 62.06,
and of spiked OEA with the same expected product ion.
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2.3.d.

Genetic Homology Study of AANAT between D. melanogaster, A. mellifera
and T. Castanaeum.
The final portion of this research into the existence and quantification of the

endogenous endocannabinoids/fatty acid amides is a brief genetic study into the
existence of a putative arylalkylamine N-acyltransferase within both T. castaneum
and A. mellifera. An AANAT recently discovered and shown to produce the requisite
chemistry in D. melanogaster (17) is compared to two similar homologs in both
organisms using the NCBI database BLASTp tool as described previously (Fig.
2.14). From the sequence comparison of the protein residues several conserved
regions were detected, showing significant sequence homology between all three
organisms. Furthermore, to aid in this comparison, a motif-sequence analysis study
of

AANAT

homology

using

MEME

Suite

(Multiple

EM

Motif

Elucidation,

http://meme.nbcr.net/meme/) was also conducted on the truncated forms of these
AANATs from all three organisms (Fig. 2.14, lower portion). These motifs are the
protein sequence regions predicted to produce distinct secondary structures of a
fully transcribed mature and active enzyme. (34) This prediction goes beyond
simple residue sequence comparison by adding a second layer of homology
determination between these enzymes. Additionally, motif prediction can determine
if an already-known catalytic site shares both sequence homology and secondary
structure homology, such as in the case of the AANAT from D. melanogaster
(wherein the Glu-47 residue was shown to be essential in the catalytic site) (35), as
it is the secondary structure that is key to the enzyme’s function. As can be seen in
Figure 2.14 there is significant sequence and corresponding motif homology
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between all four of the AANATs, as compared to the now known AANAT from D.
melanogaster.

Figure 2.14. Top: Protein residue sequence homology of AANATs showing conserved
residues/domains between D. melanogaster, DM, with A. mellifera isoforms, AM1
and AM2, and T. castaneum isoforms, TC1 and TC2. Bottom: Comparison of
sequence homology in the context of predicted secondary structure motifs between
T. castaneum, A. mellifera and D. melanogaster AANATs (specifically dopamine Nacyltransfereases). Height of each motif block indicates relative homology between
each organism.
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2.4

Conclusions and Recommendations
Because of the recent completion of genome sequencing for both the

honeybee (Apis mellifera) and red flour beetle (T. castaneum) their use as new
model organisms are now feasible, within

limitations. In conjunction, the

environmental, agricultural and potential human impact of these organisms has
made research such as this vital in recent years. With the recent discovery of
endocannabinoids and fatty acid amides in Fruit flies, and a likely enzyme in the
biosynthetic

process,

research

into

the

endocannabinoid

system

(or

the

“endocannabinome”) of insects is now of growing interest. To that end, this work
set out to identify and quantify the eCBs/FAAs in these two novel organisms in
conjunction with a brief genetic comparison using the known Fruit Fly enzyme
shown to conduct the requisite biosynthetic production of these molecules.
Based on the results presented within this work, though limited, there is now
fair evidence to support the theory that (a) the eCBs/FAAs are indeed endogenous
molecules within these two additional insect species as compared to Fruit flies and
(b) genetic comparison studies show that a known biosynthetic enzyme very likely
does exist within these insects to produce these molecules.
With the discovery of the Fruit Fly AANAT, and the homology of the AANAT
within mellifera and Tribolium, a specific biosynthetic pathway can thus be
proposed, as presented in Figure 2.15 below using N-acyldopamine as an example
based on Chapter 1.
Additionally, a new hypothesis for the in vivo/physiological activity of the
NADs based on their known quinone/indole oxidation products is now proposed.
Due to the similarities of these quinone/indole products to serotonin, the observed
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effects of the NADs as have been presented may be due to these quinone/indole
forms and not the reduced form of the N-acyldopamines. If so, the observed levels
of activity may not fully reflect the actual physiological amounts and may actually
be significantly higher. If true, the physiological impact and significance of the
NADs may also be higher.
Figure 2.15. The proposed key step in the biosynthesis of an N-acyldopamine
endocannabinoid/fatty acid amide based on AANAT sequence and motif homology
for D. melanogaster, A. mellifera and T. castaneum.

Recommendation for further research as a continuation of this work includes
refining the quantification of the endogenous levels, performing a heavy-labeled
fatty acid/fatty acid-coA feeding study, RNAi or AANAT gene expression knockout
with Tribolium, and the expression, purification and kinetic evaluation of Triboliumderived AANAT and FAAH from e. coli. The apparent absence of known receptors for
these molecules in insects also must be addressed.
Refining the endogenous levels of the eCBs/FAAs in both organisms should
proceed with a separate column isolated from any other use, preferably utilizing
ion-trap mass spectroscopy in order to “pool” the ions for better quantification and
further MS/MS studies using other fatty acid amides.
Heavy-labeled fatty acid studies with Tribolium would be relatively straight
forward and should yield significant results, similar to those presented by Jeffries,
et al. for melanogaster (12). RNAi and gene knockout studies in Tribolium are
feasible, though time-consuming, very work-intensive and may not yield results
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superior to a heavy-labeled feeding study thus far. A heavy-labeled feeding study
with mellifera would be challenging, but may be possible using heavy-labeled
glucose as a food supplement to isolated hives over a potentially significant period
of time. Such experiments may yield similar results to a feeding study with
Tribolium; however, the time frame needed may be difficult to achieve without
saturating the organism with heavy-labeled carbon atoms yet also long enough to
ensure adequate assimilation into the fatty acid biosynthetic route. A separate
possibility would be to use heavy-labeled nitrogen supplemented into the honeybee
and red flour beetle diets, making tracing the heavy-labeled molecules potentially
easier

because

of

the

existence

of

a

very

distinct

heavy

atom.

Proper

RNAi/knockouts of mellifera is not currently feasible considering the nature, needs
and behavior of the organism.
A very clear next step in furthering this work would be the expression,
purification and evaluation of a Tribolium or mellifera-based AANAT, similar to that
done in Fruit flies by Dempsey, et al. (17, 35). Doing so can further confirm the
biosynthesis of these compounds in insects using these enzymes. Additionally, the
design, expression, purification and evaluation of any possible Tribolium/melliferabased Fatty Acid Amide Hydrolase (FAAH) enzyme should also be undertaken to
begin elucidation of the degradation pathways in insects.
Furthermore, both AANAT-knockout and FAAH-knockout Tribolium

are

feasible and may yield superior results to heavy-labeled feeding studies and RNAi
experiments alone, by showing increases and decreases in endogenous levels while
further specifying the nature and mechanism of the biosynthesis and degradation of
eCBS/FAAs in these organisms.
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Lastly, the need to determine the receptor(s) paired to these compounds in
insects is a vital step in the overall progress of this research field, and may be the
most challenging to date. The receptor-ligand pairing in both organisms is key to
potentially utilizing the eCBs/FAAs in controlling or protecting Tribolium and
mellifera species, respectively.
2.5
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APPENDIX
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Figure A.1. Standard Curves and Standard MS results for
N-arachidonylethanolamine, AEA (anandamide)
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Figure A.2. Standard Curves and Standard MS results for the
N-acylethanolamine OEA (oleoylethanolamine)
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Figure A.3. Standard Curve and Standard MS Results for the N-acyldopamine
NPD. Note the presence of the quinone oxidation product in NPD at ~5.8 mins.
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Figure A.4. Standard Curve and Standard MS Results for the N-acyldopamine
NOD. Note the presence of the “shadow” or overlapping peaks between
NOD/NAD at ~5.9 mins.
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Figure A.5. Standard Curve and Standard MS Results for the N-acyldopamine
NOD. Note the presence of the “shadow” or overlapping peaks between
NOD/NAD at ~5.9 mins.
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Figure A.6. Standard Curve and Standard MS Results for N-palmitoylglycine,
NPG. Note the distinct absence of compound overlap and oxidation products and
the superior linearity as compared to the N-acyldopamine series.
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Figure A.7. Standard Curve and Standard MS Results for N-oleoylglycine, NOG.
Note the distinct absence of compound overlap and oxidation products and the
superior linearity as compared to the N-acyldopamine series.
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Figure A.8. Standard Curve and Standard MS Results for N-arachidonylglycine
NAG. Note the distinct absence of compound overlap and oxidation products and
the superior linearity as compared to the N-acyldopamine series.
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Figure A.9. Standard Curve and MS Results for N-oleoylserotonin, NOS. Note the
clearly defined oxidation and/or overlapping “shadow” peaks with NOD and NAD
at ~5.9 and ~6.2 minutes, respectively.
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Figure A.10. Standard MS Results of primary fatty acid amides linoleamide LOA
and palmitoleamide POA
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Figure A.11. Standard MS Results of primary fatty acid amides oleamide OA and
palmitamide PA
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Figure A.12. Spiked AEA, anandamide, in A. mellifera thorax showing sample matrix effects, instrument
deviation and column condition on retention time and m/z variation (Left: standard AEA, Right: aggregate
spiked thorax).
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Figure A.13. Spiked N-arachidonoyldopamine, NAD in A. mellifera thorax showing sample matrix effects,
instrument deviation and column condition on retention time and m/z variation (Left: standard NAD, Right:
aggregate spiked thorax).
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Figure A.14. Spiked N-oleoylglycine, NOG in A. mellifera thorax showing sample matrix effects, instrument
deviation and column conditions on retention time and m/z variation. Note the extensive band-broadening of
the spiked NOG sample in thorax compared to the standard sample (Left: standard NOG, Right: aggregate
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Figure A.15. Aggregate spectra and MS results of endogenous AEA in farmed

Figure A.15. Aggregate spectra and MS results of N-oleoyldopamine, NOD, in
farmed A. mellifera.
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Figure A.16. Aggregate spectra and MS of N-acylglycines NPG and NOG in
farmed A. Mellifera
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Figure A.17. Aggregate spectra and MS of N-acyl ethanolamines OEA and AEA
in feral A. Mellifera
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Figure A.18. Aggregate spectra and MS of N-acyldopamines NPD and
NOD in feral A. Mellifera. NAD is a false positive of AEA.
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Figure A.19. Aggregate spectra and MS of N-acylglycines, NPG, NOG and NAG, in
feral A. mellifera.
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Figure A.20. Aggregate spectra and MS of endogenous primary fatty acid amides
LOA and POA in feral A. mellifera.
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Figure A.21. Aggregate spectra and MS of endogenous primary fatty acid amides
OA and PA in feral A. mellifera.
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Figure A.22. Aggregate spectra and MS of endogenous ethanolamine AEA in T.
castaneum.
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Figure A.23. Aggregate spectra and MS of endogenous acyl dopamines, NPD, NOD,
and NAD, in T. castaneum.
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Figure A.24. Aggregate spectra and MS of endogenous acyl glycines, NPG, NOG and
NAG, in T. castaneum.
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Figure A.25. Aggregate spectra and MS of endogenous primary fatty acid amides,
POA, OA and PA, in T. castaneum.
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